TRIPODD: a Novel Fluorescence Imaging Platform for In Situ Quantification of Drug Distribution and Therapeutic Response
The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
Purpose Personalized medicine has largely failed to produce curative therapies in advanced cancer patients. Evaluation of in situ drug target availability (DTA) concomitant with local protein expression is critical to an accurate assessment of therapeutic efficacy, but tools capable of both are currently lacking.Procedure We developed and optimized a fluorescence imaging platform termed TRIPODD (Therapeutic Response Imaging through Proteomic and Optical Drug Distribution), resulting in the only methodology capable of simultaneous quantification of single-cell DTA and protein expression with preserved spatial context within a tumor. Using TRIPODD, we demonstrate the feasibility of combining two complementary fluorescence imaging techniques, intracellular paired agent imaging (iPAI) and cyclic immunofluorescence (cyCIF), conducted with oligonucleotide-conjugated antibodies (Ab-oligos) on tissue samples.Results We successfully performed sequential imaging on a single tissue section of iPAI to capture single-cell DTA and local protein expression heterogeneity using Ab-oligo cyCIF. Fluorescence imaging data acquisition was followed by spatial registration resulting in high dimensional data correlating DTA to protein expression at the single-cell level where uptake of a targeted probe alone was not well correlated to protein expression.Conclusion Herein, we demonstrated the utility of TRIPODD as a powerful imaging platform capable of interpreting tumor heterogeneity for a mechanistic understanding of therapeutic response and resistance through quantification of drug target availability and proteomic response with preserved spatial context at single-cell resolution.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“With the integration of intracellular paired agent imaging (iPAI) and cyclic immunofluorescence (cyCIF), the TRIPODD platform allows for simultaneous measurement of single-cell drug target availability and protein expression, revealing that DTA is not always correlated with protein expression (McMahon et al., 2021).”
From Spatial pharmacology of anti-cancer immunomodulators: a comprehensive review (2026) · cites this paper as McMahon et al., 2021
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
ilastik: interactive machine learning for (bio)image analysis
Berg, S., Kutra, D., Kroeger, T., Straehle, C. N., Kausler, B. X., Haubold, C., Schiegg, M., Ales, J., Beier, T., Rudy, M., et al. (2019) · Nature Methods · doi:10.1038/s41592-019-0582-9 · Cited by 3,368
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Molina, D. M., Jafari, R., Ignatushchenko, M., Seki, T., Larsson, E. A., Dan, C., Sreekumar, L., Cao, Y., & Nordlund, P. (2013) · Science · doi:10.1126/science.1233606 · Cited by 2,261
Intra-tumour heterogeneity: a looking glass for cancer?
Marusyk, A., Almendro, V., & Polyak, K. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3261 · Cited by 2,000
Honigberg, L. A., Smith, A. M., Sirisawad, M., Verner, E., Loury, D., Chang, B., Li, S., Pan, Z., Thamm, D. H., Miller, R. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004594107 · Cited by 1,561
Deep profiling of mouse splenic architecture with CODEX multiplexed imaging
Goltsev, Y., Samusik, N., Kennedy-Darling, J., Bhate, S., Hale, M., Vazquez, G., Black, S., & Nolan, G. P. (2018) · Cell · doi:10.1016/j.cell.2018.07.010 · Cited by 1,501
Lessons from the Cancer Genome
Garraway, L. A., & Lander, E. S. (2013) · Cell · doi:10.1016/j.cell.2013.03.002 · Cited by 1,308
Targeting Tumor Microenvironment for Cancer Therapy
Roma-Rodrigues, C., Mendes, R., Baptista, P. V., & Fernandes, A. R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040840 · Cited by 1,187
Keren, L., Bosse, M., Marquez, D., Angoshtari, R., Jain, S., Varma, S., Yang, S.-R., Kurian, A., Van Valen, D., West, R., et al. (2018) · Cell · doi:10.1016/j.cell.2018.08.039 · Cited by 1,183
Target identification using drug affinity responsive target stability (DARTS)
Lomenick, B., Hao, R., Jonai, N., Chin, R. M., Aghajan, M., Warburton, S., Wang, J., Wu, R. P., Gomez, F., Loo, J. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910040106 · Cited by 1,095
Research works printed but not linked: 1
- Chang YH et al. (2017) In 2017 39th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) 672-675
Cited by
Wang, L. G., Montaño, A. R., Combs, J. R., McMahon, N. P., Solanki, A., Gomes, M. M., Tao, K. X., Bisson, W. H., Szafran, D. A., Samkoe, K. S., et al. (2023) · Nature Chemistry · doi:10.1038/s41557-023-01173-6 · Cited by 47
Self-citationWang, C., Xu, X., Folaron, M. R., Gunn, J. R., Hodge, S., Chen, E. Y., Hoopes, P. J., Tichauer, K. M., & Samkoe, K. S. (2021) · Molecular Imaging and Biology · doi:10.1007/s11307-021-01656-3 · Cited by 38
“Finally, our collaborators developed TRIPODD (Therapeutic Response Imaging through Proteomic and Optical Drug Distribution) to evaluate in situ drug target availability with combination of paired-agent imaging and cyclic immunofluorescence [33].”
Self-citationFlexible Cyclic Immunofluorescence (cyCIF) Using Oligonucleotide Barcoded Antibodies
McMahon, N. P., Jones, J. A., Anderson, A. N., Dietz, M. S., Wong, M. H., & Gibbs, S. L. (2023) · Cancers · doi:10.3390/cancers15030827 · Cited by 15
“The primary antibody or Ab-oligo conjugate incubation was performed, as previously reported for permeabilized cells [40], permeabilized frozen tissue [41], or FFPE tissue [29],”
Self-citationMcMahon, N. P., Solanki, A., Wang, L. G., Montaño, A. R., Jones, J. A., Samkoe, K. S., Tichauer, K. M., & Gibbs, S. L. (2024) · Theranostics · doi:10.7150/thno.93256 · Cited by 6
“To bridge this unmet analytical gap, we have previously reported our novel fluorescence imaging platform, T herapeutic R esponse I maging through P roteomic and O ptical D rug D istribution ( TRIPODD ) [75].”
BackgroundMethodInfluentialSelf-citationTellurophene‐Tagging of Teniposide Facilitates Monitoring by Mass Cytometry
Rana, R., Vellanki, R. N., Wouters, B. G., & Nitz, M. (2022) · ChemBioChem · doi:10.1002/cbic.202200284 · Cited by 6
Metadata
- Authors
- McMahon, N. P., Solanki, A., Wang, L. G., Montaño, A. R., Jones, J. A., Samkoe, K. S., Tichauer, K. M., & Gibbs, S. L.
- Affiliations
- Oregon Health & Science University (US)
- Dartmouth College (US)
- Illinois Institute of Technology (US)
- Corresponding author
- Gibbs, Summer L.
- ORCID
- Venue
- Molecular Imaging and Biology
- Published
- 2021-03-09
- Volume
- 23
- Issue
- 5
- Pages
- 650-664
- ISSN
- 1536-1632 (ISSN-L)
- 1860-2002
- OpenAlex
- W3135752685
- Cited by
- 8
- References
- 71
- Citations by year
- 2026: 2 · 2024: 2 · 2023: 2 · 2022: 1 · 2021: 1
- FWCI
- 0.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Imaging and Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Mark Foundation For Cancer Research (ASPIRE Award)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biophysics › Advanced Fluorescence Microscopy Techniques
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Optical Imaging and Spectroscopy Techniques
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- drug distribution, treatment response, cyclic immunofluorescence, single-cell imaging, tumor heterogeneity, spatial registration, cancer therapy resistance, in situ proteomics
- MeSH terms
- Animals, Antineoplastic Agents, Cell Survival, Female, Fluorescent Dyes, Humans, Male, Mice, Nude, Neoplasms, Drug Delivery Systems, Intracellular Space, Cell Line, Tumor, Mice, Molecular Imaging, Precision Medicine, Optical Imaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: TRIPODD: a Novel Fluorescence Imaging Platform for In Situ Quantification of Drug Distribution and Therapeutic Response. https://app.cochat.ai/papers/10.1007/s11307-021-01589-x
- The paper
- McMahon, N. P., Solanki, A., Wang, L. G., Montaño, A. R., Jones, J. A., Samkoe, K. S., Tichauer, K. M., & Gibbs, S. L. (2021). TRIPODD: a Novel Fluorescence Imaging Platform for In Situ Quantification of Drug Distribution and Therapeutic Response. Molecular Imaging and Biology. https://doi.org/10.1007/s11307-021-01589-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.